XML 84 R43.htm IDEA: XBRL DOCUMENT
v3.25.4

COMPENSATION PLANS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract] |
Schedule of Option Activity | The following table summarizes the Company’s option activity:
| Years ended December 31,
| 2025 |  | 2024 |  | 2023
($ and shares in thousands, except per share data) | Shares | Weighted Average Exercise Price |  | Shares | Weighted Average Exercise Price |  | Shares | Weighted Average Exercise Price
Total Options: |  |  |  |  |  |  |  |
Outstanding beginning of year | 28 |  | $ | 27.55 |  |  | 171 |  | $ | 27.55 |  |  | 543 |  | $ | 29.17 |
Granted during the year | 330 |  | 92.72 |  |  | — |  | — |  |  | — |  | — |
Forfeited during the year | (45) |  | 92.72 |  |  | — |  | — |  |  | — |  | — |
Exercised during the year | — |  | — |  |  | (143) |  | 27.55 |  |  | (372) |  | 29.92 |
Outstanding end of year | 313 |  | $ | 86.86 |  |  | 28 |  | $ | 27.55 |  |  | 171 |  | $ | 27.55 |
Vested Options: |  |  |  |  |  |  |  |
Vested during the year | — |  | $ | — |  |  | — |  | $ | — |  |  | 207 |  | $ | 28.65 |
Eligible end of year for exercise | 28 |  | $ | 27.55 |  |  | 28 |  | $ | 27.55 |  |  | 171 |  | $ | 27.55 |
Aggregate intrinsic value: |  |  |  |  |  |  |  |
Total options outstanding |  | $ | 6,748 |  |  |  | $ | 1,562 |  |  |  | $ | 6,711 |
Options exercisable |  | $ | 2,275 |  |  |  | $ | 1,562 |  |  |  | $ | 6,711 |
Options exercised |  | $ | — |  |  |  | $ | 8,357 |  |  |  | $ | 10,888 |
Weighted average fair value of options granted during the year |  | $ | 26.70 |  |  |  | N/A |  |  | N/A
The following table summarizes the Company’s SARs activity:
| Years ended December 31,
| 2025 |  | 2024 |  | 2023
($ and shares in thousands, except per share data) | Shares | Weighted Average Exercise Price |  | Shares | Weighted Average Exercise Price |  | Shares | Weighted Average Exercise Price
Total SARs: |  |  |  |  |  |  |  |
Outstanding beginning of year | — |  | $ | — |  |  | 336 |  | $ | 42.89 |  |  | 336 |  | $ | 42.89 |
Granted during the year | 330 |  | 123.46 |  |  | — |  | — |  |  | — |  | — |
Forfeited during the year | (45) |  | 123.46 |  |  | — |  | — |  |  | — |  | — |
Exercised during the year | — |  | — |  |  | (336) |  | 42.89 |  |  | — |  | — |
Outstanding end of year | 285 |  | $ | 123.46 |  |  | — |  | $ | — |  |  | 336 |  | $ | 42.89 |
Vested SARs: |  |  |  |  |  |  |  |
Vested during the year | — |  | $ | — |  |  | — |  | $ | — |  |  | — |  | $ | — |
Eligible end of year for exercise | — |  | $ | — |  |  | — |  | $ | — |  |  | 336 |  | $ | 42.89 |
Aggregate intrinsic value: |  |  |  |  |  |  |  |
Total SARs outstanding |  | $ | 1,118 |  |  |  | $ | — |  |  |  | $ | 8,078 |
SARs exercisable |  | $ | — |  |  |  | $ | — |  |  |  | $ | 8,078 |
SARs exercised |  | $ | — |  |  |  | $ | 10,802 |  |  |  | $ | — |
Weighted average fair value of SARs granted during the year |  | $ | 18.78 |  |  |  | N/A |  |  | N/A
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions | The following are the assumptions that were used in calculating the fair value of stock options and SARs granted during the first quarter of 2025:
Expected term | 9 years
Expected volatility | 24 | %
Risk-free interest rate | 4.25 | %
Dividend yield | 1.77 | %
Schedule of Award Activity | A summary of restricted stock activity, including grants, vesting and forfeitures, is provided below:
| Year Ended December 31,
| 2025 |  | 2024 |  | 2023
(shares in thousands) | Shares | Weighted-Average Grant Date Stock Price |  | Shares | Weighted-Average Grant Date Stock Price |  | Shares | Weighted-Average Grant Date Stock Price
Unvested beginning of year | 989 |  | $ | 51.94 |  |  | 1,020 |  | $ | 45.65 |  |  | 1,138 |  | $ | 42.92 |
Granted during the year | 243 |  | 94.90 |  |  | 413 |  | 64.38 |  |  | 497 |  | 43.04 |
Vested during the year | (321) |  | 48.45 |  |  | (423) |  | 48.26 |  |  | (492) |  | 37.76 |
Forfeited during the year | (97) |  | 27.68 |  |  | (21) |  | 49.53 |  |  | (123) |  | 45.21 |
Unvested end of year | 814 |  | $ | 65.90 |  |  | 989 |  | $ | 51.94 |  |  | 1,020 |  | $ | 45.65 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration